Hims & Hers Health, Inc.
HIMS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,477 | $872 | $527 | $272 |
| % Growth | 69.3% | 65.5% | 93.8% | – |
| Cost of Goods Sold | $303 | $157 | $118 | $67 |
| Gross Profit | $1,173 | $715 | $409 | $204 |
| % Margin | 79.5% | 82% | 77.6% | 75.2% |
| R&D Expenses | $79 | $48 | $29 | $22 |
| G&A Expenses | $168 | $130 | $98 | $114 |
| SG&A Expenses | $847 | $576 | $371 | $250 |
| Sales & Mktg Exp. | $679 | $446 | $273 | $136 |
| Other Operating Expenses | $186 | $120 | $77 | $48 |
| Operating Expenses | $1,111 | $744 | $477 | $320 |
| Operating Income | $62 | -$29 | -$69 | -$115 |
| % Margin | 4.2% | -3.4% | -13% | -42.3% |
| Other Income/Exp. Net | $10 | $8 | $3 | $4 |
| Pre-Tax Income | $72 | -$22 | -$66 | -$111 |
| Tax Expense | -$54 | $2 | -$0 | -$3 |
| Net Income | $126 | -$24 | -$66 | -$108 |
| % Margin | 8.5% | -2.7% | -12.5% | -39.6% |
| EPS | 0.58 | -0.11 | -0.32 | -0.58 |
| % Growth | 627.3% | 65.6% | 44.8% | – |
| EPS Diluted | 0.53 | -0.11 | -0.32 | -0.58 |
| Weighted Avg Shares Out | 216 | 209 | 205 | 187 |
| Weighted Avg Shares Out Dil | 237 | 209 | 205 | 187 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $17 | $10 | $7 | $4 |
| EBITDA | $79 | -$20 | -$61 | -$111 |
| % Margin | 5.3% | -2.3% | -11.6% | -40.8% |